Table 2.

Summary of toxicities among patients with thymic epithelial tumors after radiotherapy.

No	Age	Sex	Event	Time to event (months)	Details	MLD (Gy)	Lung V20 (%)	MHD (Gy)	PA V35 (Gy)
1	58	F	G2 RP	9	Symptomatic; medication required	12.3	21.8	8.5	75.4
2	59	F	G2 RP	2	Symptomatic; medication required	13.9	20.8	18.4	99.6
3	44	F	G2 RP	9	Symptomatic; medication required	11.8	21.6	29.4	94.1
4	55	F	G2 RP	5	Symptomatic; medication required	8.3	11.4	10.3	69.5
5	50	F	G2 RP	3	Symptomatic; medication required	16.7	35.3	44.9	100
6	72	M	G2 RP	5	Symptomatic; medication required	11.4	22.8	5.0	32.3
7	63	M	G2 RP	2	Symptomatic; medication required	5.5	9.6	14.2	94.7
8	59	F	G2 RP	2	Symptomatic; medication required	17.2	37.0	33.6	100
			G3 Carditis	18	Constrictive pericarditis; pericardiotomy required
9	57	F	G2 RP	2	Symptomatic; medication required	16.3	36.6	39.8	100
			G5 Carditis	40	Heart failure due to constrictive pericarditis
10	66	M	G3 RP	1	Hospitalization required	8.5	12.9	9.3	53.5
11	70	F	G3 RP	6	Hospitalization required	12.1	26.1	18.2	85.4
12	82	M	G3 RP	2	Hospitalization required	16.3	27.7	34.3	89.9
			G3 Carditis	8	Constrictive pericarditis and effusion; conservatively managed
13	76	M	G5 RP	2	Respiratory failure due to refractory RP	17.0	33.7	14.6	100
14	56	F	G3 Carditis	9	Constrictive pericarditis; pericardiotomy required	15.3	33.0	40.7	100

Data were described as equivalent 2-Gy fractions (EQD2) using the LQ model with α/β = 3 Gy.

MLD mean lung dose, V20 percentage volume receiving at least 20 Gy, MHD mean heart dose, G grade, RP radiation pneumonitis, PA pulmonary artery, V35 percentage volume receiving at least 35 Gy.